Anti-Candida activity of fluoxetine alone and combined with fluconazole: A synergistic action against fluconazole-resistant strains

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 7, 2014, Pages 4224-4226

  Oliveira, Ana S ^a   Gaspar, Carlos A ^a   Palmeira de Oliveira, Rita ^a,b   Martinez de Oliveira, José ^a,c   Palmeira de Oliveira, Ana ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b Hospital Pharmacy Department Centro Hospitalar Cova da Beira EPE   (Portugal)

^c Centro Hospitalar Cova da Beira EPE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; FLUOXETINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; DRUG BLOOD LEVEL; KLUYVEROMYCES LACTIS; MINIMUM INHIBITORY CONCENTRATION; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; YARROWIA LIPOLYTICA; ANTIFUNGAL RESISTANCE; CANDIDIASIS, VULVOVAGINAL; CLASSIFICATION; DRUG COMBINATION; DRUG EFFECTS; DRUG POTENTIATION; FEMALE; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; FLUOXETINE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84903150603     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02623-13     Document Type: Article

References (17)

1. Goldacre MJ, Watt B, Loudon N, Milne LJ, Loudon JD, Vessey MP. 1979. Vaginal microbial flora in normal young women. Br. Med. J. 1:1450-1453. http://dx.doi.org/10.1136/bmj.1.6176.1450. (Pubitemid 9202376)
2. Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. 2004. Vaginal yeast colonization in non-pregnant women: a longitudinal study. Gynecol. Obstet. 104:926-930. http://dx.doi.org/10.1097/01.AOG.0000140687.51048.73. (Pubitemid 40458752)
3. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D. 2004. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin. Infect. Dis. 38:311-320. http://dx.doi.org/10.1086/380637. (Pubitemid 38200105)
4. Diba K, Namaki A, Ayatolahi H, Hanifian H. 2012. Rapid identification of drug resistant Candida species causing recurrent vulvovaginal candidiasis. Med. Mycol. J. 53:193-198. http://dx.doi.org/10.3314/mmj.53.193.
5. Pinto E, Pina-Vaz C, Salgueiro L, Gonçalves MJ, Costa-de-Oliveira S, Cavaleiro C, Palmeira-de-Oliveira A, Rodrigues A, Martinez-de-Oliveira J. 2006. Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. J. Med. Microbiol. 55:1367-1373. http://dx.doi.org/10.1099/jmm.0.46443-0. (Pubitemid 44651663)
6. Palmeira-De-Oliveira A, Salgueiro L, Palmeira-De-Oliveira R, Martinez-De-Oliveira J, Pina-Vaz C, Queiroz JA, Rodrigues AG. 2009. Anti-Candida activity of essential oils. Mini Rev. Med. Chem. 11:1292-1305. http://dx.doi.org/10.2174/138955709789878150.
7. Palmeira-de-Oliveira R, Antunes-Viegas D, Amaral MH, Palmeira-de-Oliveira A, Salgueiro L, Cavaleiro C, Breitenfeld L, Martinez-de-Oliveira J. 2011. Formulações com óleos essenciais: desenvolvimento de um lápis medicamentoso de Helichrysum italicum. Rev. Fitoterapia 1:57-72. (In Spanish.)
8. Palmeira-de-Oliveira A, Silva BM, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Salgueiro L. 2013. Are plant extracts a potential therapeutic approach for genital infections? Curr. Med. Chem. 20:2914-2928. http://dx.doi.org/10.2174/09298673113209990007.
9. Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M. 2001. Antifungal activity against Candida species of the selective serotonin reuptake inhibitor, sertraline. Clin. Infect. Dis. 33:135-136. http://dx.doi.org/10.1086/ 320890.
10. Young TJ, Oliver GP, Pryde D, Perros M, Parkinson T. 2003. Antifungal activity of selective serotonin reuptake inhibitors attributed to non-specific cytotoxicity. J. Antimicrob. Chemother. 51:1045-1047. http://dx.doi.org/10.1093/ jac/dkg184. (Pubitemid 36503447)
11. Lass-Flörl C, Dierich MP, Fuchs D, Semenitz E, Jenewein I, Ledochowski M. 2001. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J. Antimicrob. Chemother. 48:775-779. http://dx.doi.org/10.1093/jac/48.6.775. (Pubitemid 33735312)
12. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed, M27-A3. CLSI, Wayne, PA.
13. Cantón E, Pemán J, Viudes A, Quindós G, Gobernado M, Espinel-Ingroff A. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn. Microbiol. Infect. Dis. 45:203-206. http://dx.doi.org/10.1016/S0732-8893(02)00525-4. (Pubitemid 36349661)
14. Ernst EJ, Rogers PD (ed). 2005. Methods in molecular medicine, vol 118. Antifungal agents. Humana Press Inc., Totowa, NJ.
15. Clinical and Laboratory Standards Institute. 2012. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th informational supplement. Document M27-S4. CLSI, Wayne, PA.
16. Paykel ES. 1992. Handbook of affective disorders, 2nd ed. Guilford Press, New York, NY.
17. Tremaine LM, Welch WM, Ronfeld RA. 1989. Metabolism and disposition of the 5 hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab. Dispos. 17:542-550. (Pubitemid 19244919)